Medtronic ($MDT): That October Volume Was the Exchange Offer, Not Distribution — Now It Has to Clear $105

Medtronic ($MDT): That October Volume Was the Exchange Offer, Not Distribution — Now It Has to Clear $105

If you’ve read my book, The Complete Guide to Volume Price Analysis, you know the market’s golden rule. Volume is the effort, while the price spread is the result. When these two elements fall out of sync, the market presents us with an anomaly. And anomalies are where smart money leaves its deepest footprints.

The Exchange Offer Explains the Volume

On October 8, the Medtronic candle formed on massive volume, the largest ever. At first glance, it looked decisive, but it turned out to be something else entirely. Roughly 105 million shares changed hands inside a compressed range that closed higher on the day. From a VPA perspective, it is a glaring anomaly: heavy effort with limited result. The usual question is whether institutions were quietly distributing into resistance. However, in this case, the answer lies in the calendar and what was going on behind the scenes with Medtronic.

Medtronic was in the final days of its exchange offer for the remaining MiniMed stake. On 7 October, the final ratio of 4.5939 MiniMed shares per MDT share was fixed. The offer expired at midnight on 9 October, and it was heavily oversubscribed.

Arbitrage desks, index funds, and holders had to decide whether to tender or withdraw, thereby generating this monster volume. The Dollar volume on the day was between $9.1 and $9.2 billion, confirming the flow was two-sided, while the price stayed within a very tight $2.93 range. The later volume spikes around settlement (14–16 October) followed the same pattern. This was known-event volume, not a classic distribution print at a ceiling.

That same volume cluster also carried MDT through the 200-day and 200-week averages. And since then, the stock has continued higher and is now pressing the upper edge of a multi-year monthly base.

The $105 Ceiling on the Monthly Chart

On the monthly chart, that upper edge sits around $105—a level that has already rejected the stock 4 times. (See above)

The weekly chart shows the same zone as the range’s clear ceiling, which has contained the stock since 2023, with solid support at $75. It is a long, grinding base, and its top is now being retested after a volume-driven push through the longer-term moving averages.

Options – Is the Tail Wagging the Dog?

From an options perspective, $MDT is above the gamma flip at $88.77, with the call wall sitting at $100. With only a day left until expiry, dealers will keep price pinned between those two levels and hedge to dampen volatility unless the price either breaks the wall or falls back through the flip. In addition, the put/call ratio has risen from 0.11 to 0.19.  While still low, this confirms calls still dominate, but the uptick suggests some hedging and/or profit-taking.

On 29 October, options volume was 12,766 contracts against roughly 5 million shares of stock volume. That gives an options-to-stock ratio of about 0.26 (options volume × 100 ÷ stock volume). A ratio under 0.5 is standard for a name like MDT; it would need to be closer to 1.0 or higher before options flow dominates.  In other words, the tail could be said to be wagging the dog. At present, the stock is still driving the options, not the other way around. Volume and open interest remain consistent with a stock that has just cleared a known corporate event and is now probing a well-defined resistance zone rather than being driven by options positioning alone.

Institutional Support at $94.97

Meanwhile, institutional activity reinforces the same picture. The largest print cluster sits at $94.97, where roughly $6.47 billion changed hands. That level sits just below the current price and aligns with the zone that absorbed the exchange-offer volume. Holding above keeps the path open toward $100 and on toward the $105 region. However, any sustained break lower through this region puts the 200-day back in play.

From a fundamental perspective, analysts remain constructive despite expecting upcoming earnings (17th November) to show a single-digit profit dip.  The consensus view is that the MiniMed separation is ultimately positive, leaving Medtronic to focus on its cardiovascular, neuroscience, and surgical portfolios, and that its balance sheet and cash-flow profile support continued capital returns. This backdrop doesn’t override the chart, but it helps explain why dips have been bought once the event volume cleared.

What Has to Happen Next

Where price goes next is very much a level-by-level question. A clean weekly close above $105 — the top of those four failed breakouts — would be the first real confirmation that the multi-year base is resolving higher, opening the door toward the next monthly resistance near $110 – $115 and eventually the $134 area.

Failure at $105, especially on rising volume on a narrow-spread candle with or without an upper wick, would be a red flag and a classic distribution signal. $MDT would then target the $94.97 dark-pool node as initial support. As the daily chart shows, there is also minor support in the $92 region (pink line), and below that, we have the 200 MA at $89.65 on the weekly chart and $88.90 on the daily.

For now, the stock is testing the top of a four-year base after a mechanical, rather than a discretionary, volume event. The anomaly of October 8 was the catalyst for the push through the moving averages. The reaction at $105 will decide whether that push has room to run further.

If you are keen to learn more and apply volume price analysis to your own trading and investing, we have created two programs for self-directed students whether for stocks or forex. Join us now to take your trading skills to another level.

By Anna Coulling – creator of volume price analysis

By Anna Coulling – creator of volume price analysis